A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.
about
Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer.Combination of mTOR and MAPK Inhibitors-A Potential Way to Treat Renal Cell Carcinoma.Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1
P2860
A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
A potent therapeutics for gall ...... K and mTOR signaling networks.
@en
A potent therapeutics for gall ...... K and mTOR signaling networks.
@nl
type
label
A potent therapeutics for gall ...... K and mTOR signaling networks.
@en
A potent therapeutics for gall ...... K and mTOR signaling networks.
@nl
prefLabel
A potent therapeutics for gall ...... K and mTOR signaling networks.
@en
A potent therapeutics for gall ...... K and mTOR signaling networks.
@nl
P2093
P2860
P1476
A potent therapeutics for gall ...... K and mTOR signaling networks.
@en
P2093
Hideaki Ijichi
Hiroyuki Isayama
Keisuke Tateishi
Koji Miyabayashi
Minoru Tada
Ryota Takahashi
Takashi Sasaki
Tsuneo Ikenoue
Yasuo Tanaka
P2860
P304
P356
10.1007/S00535-015-1145-1
P577
2015-11-27T00:00:00Z